150 related articles for article (PubMed ID: 7681620)
1. [Symptoms and signs of benign prostate hypertrophy (BPH)].
Imai K; Kurokawa K; Sekihara T; Suzuki T; Yamanaka H; Takahashi H; Mashimo T; Takahashi O; Kitaura K; Saruki K
Hinyokika Kiyo; 1993 Jan; 39(1):15-22. PubMed ID: 7681620
[TBL] [Abstract][Full Text] [Related]
2. Relationship between lower urinary tract symptoms and objective measures of benign prostatic hyperplasia: a Chinese survey.
Wang JY; Liu M; Zhang YG; Zeng P; Ding Q; Huang J; He DL; Song B; Kong CZ; Pang J
Chin Med J (Engl); 2008 Oct; 121(20):2042-5. PubMed ID: 19080272
[TBL] [Abstract][Full Text] [Related]
3. Definition of at-risk patients: dynamic variables.
Emberton M
BJU Int; 2006 Apr; 97 Suppl 2():12-5; discussion 21-2. PubMed ID: 16507047
[TBL] [Abstract][Full Text] [Related]
4. Risk factors for lower urinary tract symptoms suggestive of benign prostatic hyperplasia in a community based population of healthy aging men: the Krimpen Study.
Kok ET; Schouten BW; Bohnen AM; Groeneveld FP; Thomas S; Bosch JL
J Urol; 2009 Feb; 181(2):710-6. PubMed ID: 19091352
[TBL] [Abstract][Full Text] [Related]
5. [Uroflowmetry and its influence factors in benign prostate hyperplasia patients].
Zhong KB; Jiang XZ; Peng CY
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2005 Feb; 30(1):99-101, 120. PubMed ID: 15871201
[TBL] [Abstract][Full Text] [Related]
6. Effect of voiding position on uroflowmetric parameters and post-void residual urine volume in patients with benign prostatic hyperplasia.
Unsal A; Cimentepe E
Scand J Urol Nephrol; 2004; 38(3):240-2. PubMed ID: 15204379
[TBL] [Abstract][Full Text] [Related]
7. Functional and anatomical effects of hormonally induced experimental prostate growth: a urodynamic model of benign prostatic hyperplasia (BPH) in the beagle.
Yokota T; Honda K; Tsuruya Y; Nomiya M; Yamaguchi O; Gotanda K; Constantinou CE
Prostate; 2004 Feb; 58(2):156-63. PubMed ID: 14716740
[TBL] [Abstract][Full Text] [Related]
8. [Contribution of pressure-flow relationship studies in the evaluation of benign hypertrophy of the prostate].
Haab F
Prog Urol; 1999 Feb; 9(1):151-5. PubMed ID: 10212970
[TBL] [Abstract][Full Text] [Related]
9. Data from frequency-volume charts versus maximum free flow rate, residual volume, and voiding cystometric estimated urethral obstruction grade and detrusor contractility grade in men with lower urinary tract symptoms suggestive of benign prostatic hyperplasia.
Van Venrooij GE; Eckhardt MD; Boon TA
Neurourol Urodyn; 2002; 21(5):450-6. PubMed ID: 12232879
[TBL] [Abstract][Full Text] [Related]
10. [Study on patients with benign prostate hyperplasia treated by the therapeutic regimen of watchful waiting during a twenty-four-month follow-up period].
Zhang YG; Wang JY; Liu M; Xu J; Wu JY; Xin Y; Wan B; Wei D; Zhu SC; Zeng P
Zhonghua Liu Xing Bing Xue Za Zhi; 2008 Jun; 29(6):611-3. PubMed ID: 19040049
[TBL] [Abstract][Full Text] [Related]
11. Transurethral resection of the prostate (TURP)--in the treatment of benign prostatic hypertrophy (BPH) in Mekelle, Ethiopia.
Alemu MH
Ethiop Med J; 2009 Jan; 47(1):65-9. PubMed ID: 19743783
[TBL] [Abstract][Full Text] [Related]
12. [Diagnosis of infravesical obstruction in patients with benign prostatic hyperplasia].
Al'-Shukri SKh; Amdiĭ RE
Urologiia; 2006; (2):41-3, 45. PubMed ID: 16708588
[TBL] [Abstract][Full Text] [Related]
13. [Studies of the new parameter based on the urinary flow rate curve in benign prostatic hypertrophy].
Haraguchi C
Hinyokika Kiyo; 1989 Jan; 35(1):43-9. PubMed ID: 2471399
[TBL] [Abstract][Full Text] [Related]
14. Diagnostic and predictive value of voiding diary data versus prostate volume, maximal free urinary flow rate, and Abrams-Griffiths number in men with lower urinary tract symptoms suggestive of benign prostatic hyperplasia.
van Venrooij GE; van Melick HH; Eckhardt MD; Boon TA
Urology; 2008 Mar; 71(3):469-74. PubMed ID: 18342189
[TBL] [Abstract][Full Text] [Related]
15. [Correlation of benign prostatic hyperplasia with hyperlipemia].
Li PJ; Zhang XH; Guo LJ; Na YQ
Zhonghua Wai Ke Za Zhi; 2005 Mar; 43(6):387-9. PubMed ID: 15854349
[TBL] [Abstract][Full Text] [Related]
16. Long-term results of contact laser versus transurethral resection of the prostate in the treatment of benign prostatic hyperplasia with small or moderately enlarged prostates.
Tuhkanen K; Heino A; Aaltomaa S; Ala-Opas M
Scand J Urol Nephrol; 2003; 37(6):487-93. PubMed ID: 14675922
[TBL] [Abstract][Full Text] [Related]
17. Age related urodynamic changes in patients with benign prostatic hyperplasia.
Madersbacher S; Klingler HC; Schatzl G; Stulnig T; Schmidbauer CP; Marberger M
J Urol; 1996 Nov; 156(5):1662-7. PubMed ID: 8863566
[TBL] [Abstract][Full Text] [Related]
18. [The current approach to the management of benign hypertrophy of the prostate].
Abbou CC; Salomon L; Chopin D; Ravery V; Haillot O
Ann Urol (Paris); 1996; 30(6-7):294-301; discussion 302-10. PubMed ID: 9092383
[TBL] [Abstract][Full Text] [Related]
19. [Clinical effectiveness and safety study of combined therapy with an alpha-blocker and an anticholinergic for patients with LUT/BPH].
Xiao H; Li HZ; Yang Y; Huang ZM; Li YQ; Zhao XF
Zhonghua Yi Xue Za Zhi; 2007 Jun; 87(23):1590-3. PubMed ID: 17803845
[TBL] [Abstract][Full Text] [Related]
20. [Clinical effects of allylestrenol on patients with benign prostatic hyperplasia (BPH) evaluated with criteria for treatment efficacy in BPH].
Noguchi K; Takeda M; Hosaka M; Kubota Y
Hinyokika Kiyo; 2002 May; 48(5):269-73. PubMed ID: 12094708
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
